Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tropisetron sensitizes α7 containing nicotinic receptors to low levels of acetylcholine in vitro and improves memory-related task performance in young and aged animals
Patrick M. Callahan, Daniel Bertrand, Sonia Bertrand, et al.
Neuropharmacology (2017) Vol. 117, pp. 422-433
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

HPLC-DAD finger printing, antioxidant, cholinesterase, and α-glucosidase inhibitory potentials of a novel plant Olax nana
Muhammad Ovais, Muhammad Ayaz, Ali Talha Khalil, et al.
BMC Complementary and Alternative Medicine (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 126
Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease
Kaige Ma, Yi‐Hua Qian
Neuropeptides (2018) Vol. 73, pp. 96-106
Closed Access | Times Cited: 118
The wonderland of neuronal nicotinic acetylcholine receptors
Daniel Bertrand, Alvin V. Terry
Biochemical Pharmacology (2017) Vol. 151, pp. 214-225
Closed Access | Times Cited: 114
The current agonists and positive allosteric modulators of α 7 nAChR for CNS indications in clinical trials
Taoyi Yang, Ting Xiao, Qi Sun, et al.
Acta Pharmaceutica Sinica B (2017) Vol. 7, Iss. 6, pp. 611-622
Open Access | Times Cited: 104
5-HT3Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface
Gohar Fakhfouri, Reza Rahimian, Jonas Dyhrfjeld‐Johnsen, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 383-412
Open Access | Times Cited: 88
α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future
Alvin V. Terry, Patrick M. Callahan
Neuropharmacology (2020) Vol. 170, pp. 108053-108053
Open Access | Times Cited: 72
Targeting α7 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug development
Lindsay H. Burns, Zhe Pei, Hoau‐Yan Wang
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1085-1095
Closed Access | Times Cited: 24
5-HT3 Receptor Antagonism: A Potential Therapeutic Approach for the Treatment of Depression and other Disorders
Shvetank Bhatt, Thangaraj Devadoss, S. N. Manjula, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 9, pp. 1545-1559
Open Access | Times Cited: 65
Recent advances with 5‐HT3 modulators for neuropsychiatric and gastrointestinal disorders
Radomír Jůza, Přemysl Vlček, Eva Mezeiová, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 1593-1678
Closed Access | Times Cited: 43
α7 nicotinic acetylcholine receptors in the hippocampal circuit: taming complexity
Ayland C. Letsinger, Zhenglin Gu, Jerrel L. Yakel
Trends in Neurosciences (2021) Vol. 45, Iss. 2, pp. 145-157
Open Access | Times Cited: 41
A Review of the Cholinergic System and Therapeutic Approaches to Treat Brain Disorders
Daniel Bertrand, Tanya L. Wallace
Current topics in behavioral neurosciences (2020), pp. 1-28
Closed Access | Times Cited: 40
Experimental Models for the Discovery of Novel Anticonvulsant Drugs: Focus on Pentylenetetrazole-Induced Seizures and Associated Memory Deficits
Alaa Alachkar, Shreesh Ojha, Adel Sadeq, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 15, pp. 1693-1711
Closed Access | Times Cited: 39
Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery
Alvin V. Terry, Patrick M. Callahan
Nicotine & Tobacco Research (2018) Vol. 21, Iss. 3, pp. 383-394
Open Access | Times Cited: 35
The Histamine H3 Receptor Antagonist DL77 Ameliorates MK801-Induced Memory Deficits in Rats
Nermin Eissa, Nadia Khan, Shreesh Ojha, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 27
Tropisetron inhibits sepsis by repressing hyper-inflammation and regulating the cardiac action potential in rat models
Zhengjiang Liu, Zhiheng Zeng, Changdong Wu, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 110, pp. 380-388
Open Access | Times Cited: 22
Using Xenopus oocytes in neurological disease drug discovery
Steven L. Zeng, Leland C. Sudlow, Mikhail Y. Berezin
Expert Opinion on Drug Discovery (2019) Vol. 15, Iss. 1, pp. 39-52
Open Access | Times Cited: 22
Biochemical Profiling and Elucidation of Biological Activities of Beta vulgaris L. Leaves and Roots Extracts
Sidra Rehman, Shifa Shah, Azeem Mehmood Butt, et al.
Saudi Journal of Biological Sciences (2020) Vol. 28, Iss. 1, pp. 592-602
Open Access | Times Cited: 20
A cellular approach to understanding and treating Gulf War Illness
Philip L. Yates, Ankita Patil, Xiaohuan Sun, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 21-22, pp. 6941-6961
Open Access | Times Cited: 16
Tropisetron ameliorates cyclophosphamide-induced hemorrhagic cystitis in rats
Mohammad Reza Zirak, Gholamreza Karimi, Reza Rahimian, et al.
European Journal of Pharmacology (2020) Vol. 883, pp. 173310-173310
Closed Access | Times Cited: 18
Tropisetron enhances recognition memory in rats chronically treated with risperidone or quetiapine
Indrani Poddar, Patrick M. Callahan, Caterina M. Hernandez, et al.
Biochemical Pharmacology (2017) Vol. 151, pp. 180-187
Open Access | Times Cited: 17
Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review
Kyle Arsenault‐Mehta, Mario Hochman‐Bérard, Alexander W. Johnson, et al.
Neuropsychopharmacology Reports (2023) Vol. 44, Iss. 1, pp. 2-16
Open Access | Times Cited: 5
<p>Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats</p>
Alaa Alachkar, Nadia Khan, Dorota Łażewska, et al.
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 531-542
Open Access | Times Cited: 15
Tropisetron attenuates tumor growth and progression in an experimental model of mouse lung cancer
Mohsen Rashidi, Ali Bazı, Mohammad Reza Shiran, et al.
Journal of Cellular Biochemistry (2019) Vol. 121, Iss. 2, pp. 1610-1622
Closed Access | Times Cited: 15
Mini-review: Aging of the neuroendocrine system: Insights from nonhuman primate models
Jacques Epelbaum, Jérémy Terrien
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 100, pp. 109854-109854
Closed Access | Times Cited: 15
Chronic oral treatment with risperidone impairs recognition memory and alters brain-derived neurotrophic factor and related signaling molecules in rats
Indrani Poddar, Patrick M. Callahan, Caterina M. Hernandez, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 189, pp. 172853-172853
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top